obesity and sarcopenia.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults who are physically inactive; age between 18 and 60 years; both sexes; submitted to bariatric surgery for more than 5 years, by the Unified Health System (SUS) or in private clinics; residents of the Federal District
Exclusion criteria
Exclusion criteria: Individuals who are physically active through the performance of any type of regular and/or programmed vigorous physical exercise; who presents any decompensated chronic illness or any evident illness that prevents from exercising; pregnant women; women who are breastfeeding; individuals who have psychiatric disorders in the use of psychotropic drugs; who use a pacemaker; in use of hormone therapy or on medication for weight loss; those who have any type of amputation; who do not have access to a cell phone or computer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of the multicomponent intervention on sarcopenic obesity markers evaluated according to the consensus on sarcopenic obesity developed by the European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO). The markers will be the force of palmar pressure, through the dynamometer; a body composition, measured by the dual-energy x-ray absorptiometry technique; functionality and muscle strength through testicles such as sit and stand, timed up and go (TUG), and a five-minute walk. It is expected that after 12 weeks of multicomponent intervention, there will be a significant improvement (p<0.05) in muscle strength and function, verified through the improvement of performance in functional tests and body composition, with a reduction in body weight, an increase in the percentage of fat-free mass, and reduction of the percentage of adipose tissue | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the effect of the multicomponent intervention on the participant's global health. Global health will be assessed using office blood pressure, biochemical markers (plasma concentrations of glucose, insulin, glycated hemoglobin, blood count, lipogram), liver function (concentrations of oxaloacetate transaminase and glutamic pyruvic transaminase), markers of renal function (urea serum creatinine, glomerular filtration rate), sleep quality, using the Pittsburgh Sleep Quality Index, and resting energy expenditure, using indirect calorimetry. The usual food consumption will be evaluated, through the application of a 24-hour recall, and the quality of the diet, through the application of the ultra-processed food consumption tracking instrument, applied in the Risk and Protective Factors Surveillance System for Chronic Diseases by Telephone Inquiry (VIGITEL). Eating behavior and body image perception will be evaluated through the application of validated questionnaires, the Three Factor Eating Questionnaire (TFEQ), and the Body Appreciation Scale (BAS), respectively. It is expected that after 12 weeks of multicomponent intervention, there will be a significant improvement (p<0.05) in health markers, through the improvement of biochemical markers, and sleep quality; food consumption, by increasing the amount and frequency of in unprocessed and minimally processed foods with low caloric density, and reducing the consumption of ultra-processed foods with high caloric density; and improvement of eating behavior, by reducing scores related to emotional eating, dismayed eating, uncontrolled eating, and increased conscious eating and body appreciation | — |
Countries
Brazil
Contacts
Universidade de Brasília